Asia > Southern Asia > India > GlaxoSmithKline to Invest in Nigerian and Indian Businesses

India: GlaxoSmithKline to Invest in Nigerian and Indian Businesses

2013/03/17

Britian’s major drugmaker, GlaxoSmithKline Plc (GSK) has disclosed plans to invest $1 billion in its Nigerian and Indian units, in a bid to reduce reliance on pharmaceutical products and western markets and increase shares in the fast growing emerging markets.

Pharmaceutical giant, GSK said on Monday it will spend $98 million to acquire an additional 33.7 % share in its GlaxoSmithKline Consumer Nigeria Plc, shooting its total holdings to 80 % from 46.4 %, leaving the minimum 20 % public shareholding required for a company to remain listed on the Nigerian Stock Exchange (NSE).

For the additional shares, the group is proposing a premium of 28 % at 48 naira (30 cents) per share.

David Redfern, Chief Strategy Officer, GSK said: “This Proposition to increase GSK’s ownership of GlaxoSmithKline Consumer Nigeria reiterates our long term support of the Company’s strategy and our confidence in the continuing increase prospects of the business.”

The Nigerian unit of the drug vendor generated a turnover of over 21.5 billion naira ($140 million) in 2011, with consumer healthcare products like Lucozade, Horlicks, part others, accounting for 70 % of the company’s revenue.

Last year in India, the Horlicks brand, which is one of the majority popular health drinks in the region, contributed $432 million in sales to the Indian unit, making up almost three-quarters of total revenues.

“A lot of the current business of Horlicks is in the south and the east of India. So there is still a great opportunity to increase the penetration to the north and the west,” Redfern said in an interview to Reuters.

GSK plans to purchase a 31.8 % stake in India’s GlaxoSmithKline Consumer Healthcare Ltd for about $940 million by offering a public offer of 28 % premium at $70.16 per share.

The offer will see the group’s stake in the Indian consumer products unit jump to 75 % from 43.2 %.

GSK has said the Indian and Nigerian transactions will be funded through existing cash resources and won’t impact expectations for the group’s long-term share buy-back program.

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom. Listed on the London Stock Exchange and the New York bourse, the group is rated as the world’s fourth-major pharmaceutical company measured by 2009 prescription drug sales (next Pfizer, Novartis, and Sanofi). It was established in 2000 by the merger of Glaxo Wellcome plc and SmithKline Beecham plc.

Comments

Related Articles

Mauritius has gone ‘extra mile’ for India tax treaty
2013/05/20 Hopeful of reaching an agreement any minute at this time on the long-pending revision of tax treaty with India, Mauritius says it has gone ‘additional mile’ to ensure that the pact does not get misused for illicit activities like money laundering and round-tripping of funds. Mauritius is willing to take even further steps to resolve any pending issues and reach a “win-win situation” for both the nations, as the treaty has been mutually beneficial in the completed three decades, the country’s Vice Prime Minister and Minister of Finance and Economic Development Xavier Luc Duval told PTI in an interview.
India, China sign series of MoUs to address trade deficit issues
2013/05/20 India and China, on Monday, signed a series of memorandum of understandings (MoUs) on pharmaceuticals, buffalo meat and fisheries and an agreement on feed and feed ingredients to address the growing concern on trade deficit issues. The trade deficit has increased from $1.08 billion in 2001-02 to $40.77 billion in 2012-13. The MoUs were signed as part of the visit of the Chinese Premier Li Keqiang to India.
China hopes to boost its relations with India
2013/05/09 China hopes to boost its relations with India through Indian Foreign Minister Salman Khurshid's upcoming visit, Foreign Ministry spokeswoman Hua Chunying said at a Wednesday press briefing. Hua's remarks came in response to a question about Khurshid's visit, inclunding a recent boundary dispute between the two nations.
Indonesia overtakes India as the most optimistic market
2013/05/02 Indonesia overtook India as the majority optimistic consumer market globally, according to a survey by world data and insights company Nielsen. Japan, where the central bank has aggressively boosted economic stimulus, reported its highest consumer confidence score since 2006 although Japanese were still very cautious about the outlook.
India's Corporate elite and the enduring power of familly dynasties
2013/05/01 In January, at the same time as Rahul Gandhi finally accepted the post of vice president of the Congress party – the country’s dominant political party since its independence in 1947 – thousands of elected representatives and millions of supporters were relieved. The next of both the party and the country was presently ensured. It happened the usual way for Congress: the heir of the Gandhi family was appointed. At no time mind that for a very long time Rahul balked at the responsibility to become the party’s number two, alongside his mother Sonia, the party’s president. His father, Rajiv, served as Prime Minister of India, and so did his grandmother, Indira – they were both assassinated.